Influenza A viruses (IAVs) are zoonotic pathogens that cause yearly outbreaks with high
rates of morbidity and fatality. The virus continuously acquires point mutations while …

OBJECTIVES: The objective of this review is to provide updated information on the clinical
spectrum and natural history of human influenza, including risk factors for severe disease …

Ribavirin is a broad antiviral compound with demonstrated activity against herpes simplex
virus (HSV), human immunodeficiency virus HIV-1, influenza virus, respiratory syncytial …

Abstract Aims: Influenza A virus (IAV), a major airborne pathogen, is closely associated with
significant morbidity and mortality. The primary target for influenza virus replication is the …

Duration of viral shedding following infection is an important determinant of disease
transmission, informing both control policies and disease modelling. We undertook a …

Background. We describe the impact of early initiation of influenza antiviral treatment among
pregnant women hospitalized with laboratory-confirmed influenza during the 2010–2014 …

Cancer patient care requires a multi-disciplinary approach and multiple medical and ethical
considerations. Clinical care during a pandemic health crisis requires prioritising the use of …

Background: During March 2009 a novel Influenza A virus emerged in Mexico. We describe
the clinical picture of the pandemic Influenza A (H1N1) Influenza in cancer patients during …

Individuals with metabolic dysregulation of cellular glycosylation often experience severe
influenza disease, with a poor immune response to the virus and low vaccine efficacy. Here …

The influenza virus causes acute respiratory infections, leading to high morbidity and
mortality in groups of patients at higher risk. Antiviral drugs represent the first line of defense …